Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Radiat Oncol ; 19(1): 51, 2024 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-38649902

RESUMO

BACKGROUND: Radiation-induced liver damage (RILD) occasionally occurs following carbon-ion radiotherapy (CIRT) for liver tumors, such as hepatocellular carcinoma (HCC), in patients with impaired liver function disease. However, the associated risk factors remain unknown. The present study aimed to determine the risk factors of RILD after CIRT. METHODS: We retrospectively analyzed 108 patients with HCC treated with CIRT at the Osaka Heavy Ion Therapy Center between December 2018 and December 2022. RILD was defined as a worsening of two or more points in the Child-Pugh score within 12 months following CIRT. The median age of the patients was 76 years (range 47-95 years), and the median tumor diameter was 41 mm (range 5-160 mm). Based on the pretreatment liver function, 98 and 10 patients were categorized as Child-Pugh class A and B, respectively. We analyzed patients who received a radiation dose of 60 Gy (relative biological effectiveness [RBE]) in four fractions. The median follow-up period was 9.7 months (range 2.3-41.1 months), and RILD was observed in 11 patients (10.1%). RESULTS: Multivariate analysis showed that pretreatment Child-Pugh score B (p = 0.003, hazard ratio [HR] = 6.90) and normal liver volume spared from < 30 Gy RBE (VS30 < 739 cm3) (p = 0.009, HR = 5.22) were significant risk factors for RILD. The one-year cumulative incidences of RILD stratified by Child-Pugh class A or B and VS30 < 739 cm3 or ≥ 739 cm3 were 10.3% or 51.8% and 39.6% or 9.2%, respectively. CONCLUSION: In conclusion, the pretreatment Child-Pugh score and VS30 of the liver are significant risk factors for RILD following CIRT for HCC.


Assuntos
Carcinoma Hepatocelular , Radioterapia com Íons Pesados , Neoplasias Hepáticas , Lesões por Radiação , Humanos , Neoplasias Hepáticas/radioterapia , Carcinoma Hepatocelular/radioterapia , Radioterapia com Íons Pesados/efeitos adversos , Idoso , Masculino , Pessoa de Meia-Idade , Feminino , Estudos Retrospectivos , Idoso de 80 Anos ou mais , Prognóstico , Lesões por Radiação/etiologia , Lesões por Radiação/patologia , Fatores de Risco , Fígado/efeitos da radiação , Fígado/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA